CAPLACIZUMAB

CAPLACIZUMAB was reported 1784 times

These side effects are most commonly reported by patients taking CAPLACIZUMAB:

# Side effect Count
0 PRODUCT USE IN UNAPPROVED INDICATION 619
1 OFF LABEL USE 208
2 ADAMTS13 ACTIVITY DECREASED 161
3 EPISTAXIS 133
4 PLATELET COUNT DECREASED 133
5 FATIGUE 111
6 CONTUSION 89
7 THROMBOTIC THROMBOCYTOPENIC PURPURA 84
8 HEADACHE 83
9 INJECTION SITE PAIN 82
10 CONDITION AGGRAVATED 80
11 ADAMTS13 ACTIVITY ABNORMAL 73
12 INJECTION SITE BRUISING 70
13 HOSPITALISATION 50
14 GINGIVAL BLEEDING 49
15 HAEMORRHAGE 48
16 HAEMOGLOBIN DECREASED 47
17 PLATELET COUNT ABNORMAL 47
18 ARTHRALGIA 43
19 PLATELET COUNT INCREASED 41
20 DYSPNOEA 39
21 RASH 39
22 ASTHENIA 37
23 PAIN 37
24 GASTROINTESTINAL HAEMORRHAGE 34
25 DRUG INEFFECTIVE 33
26 PYREXIA 33
27 INJECTION SITE ERYTHEMA 32
28 INJECTION SITE HAEMORRHAGE 31
29 PRODUCT DOSE OMISSION ISSUE 28
30 THROMBOSIS 27
31 INSOMNIA 26
32 BLOOD LACTATE DEHYDROGENASE INCREASED 25
33 THROMBOCYTOPENIA 25
34 INJECTION SITE PRURITUS 24
35 ANXIETY 23
36 DISEASE RECURRENCE 23
37 HEAVY MENSTRUAL BLEEDING 23
38 DEEP VEIN THROMBOSIS 22
39 MUSCLE SPASMS 22
40 ANAEMIA 21
41 MYALGIA 21
42 NAUSEA 21
43 BACK PAIN 20
44 PRURITUS 20
45 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20
46 DIZZINESS 19
47 FEELING ABNORMAL 19
48 HYPERTENSION 19
49 PARAESTHESIA 19
50 CEREBROVASCULAR ACCIDENT 18
51 INJECTION SITE RASH 18
52 CONSTIPATION 17
53 DEATH 17
54 MALAISE 17
55 PAIN IN EXTREMITY 17
56 UNEVALUABLE EVENT 17
57 VAGINAL HAEMORRHAGE 17
58 BLOOD GLUCOSE INCREASED 16
59 COVID-19 16
60 HAEMATOCRIT DECREASED 16
61 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16
62 RECTAL HAEMORRHAGE 16
63 CEREBRAL HAEMORRHAGE 15
64 DIARRHOEA 15
65 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15
66 HAEMOGLOBIN ABNORMAL 15
67 INFECTION 15
68 ISCHAEMIC STROKE 15
69 LABORATORY TEST ABNORMAL 15
70 MATERNAL EXPOSURE DURING PREGNANCY 15
71 PERIPHERAL SWELLING 15
72 HYPERSENSITIVITY 14
73 JOINT SWELLING 14
74 PNEUMONIA 14
75 SEIZURE 14
76 VOMITING 14
77 CARDIAC ARREST 13
78 CHEST PAIN 13
79 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13
80 HAEMATOCHEZIA 13
81 PULMONARY EMBOLISM 13
82 RENAL IMPAIRMENT 13
83 CATHETER SITE HAEMORRHAGE 12
84 COUGH 12
85 TREMOR 12
86 ACNE 11
87 HAEMOPTYSIS 11
88 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11
89 INTENTIONAL PRODUCT USE ISSUE 11
90 WHITE BLOOD CELL COUNT INCREASED 11
91 ABDOMINAL DISTENSION 10
92 ABDOMINAL PAIN 10
93 BLOOD PRESSURE INCREASED 10
94 BODY TEMPERATURE INCREASED 10
95 CHILLS 10
96 FOETAL EXPOSURE DURING PREGNANCY 10
97 FOETAL GROWTH RESTRICTION 10
98 HAEMATOMA 10
99 MOOD ALTERED 10
100 RASH MACULAR 10
101 RED BLOOD CELL COUNT DECREASED 10
102 BLOOD LACTATE DEHYDROGENASE ABNORMAL 9
103 ERYTHEMA 9
104 HAEMATEMESIS 9
105 HAEMATOCRIT ABNORMAL 9
106 ILLNESS 9
107 INCORRECT PRODUCT ADMINISTRATION DURATION 9
108 NO ADVERSE EVENT 9
109 OLIGOHYDRAMNIOS 9
110 PALPITATIONS 9
111 PETECHIAE 9
112 PHLEBITIS 9
113 PRODUCT STORAGE ERROR 9
114 RED BLOOD CELL COUNT ABNORMAL 9
115 SWELLING FACE 9
116 URTICARIA 9
117 WEIGHT INCREASED 9
118 WHITE BLOOD CELL COUNT ABNORMAL 9
119 ALANINE AMINOTRANSFERASE INCREASED 8
120 CEREBRAL INFARCTION 8
121 DISEASE PROGRESSION 8
122 FALL 8
123 GAIT DISTURBANCE 8
124 HOT FLUSH 8
125 HYPERHIDROSIS 8
126 INCORRECT DOSE ADMINISTERED 8
127 INFLUENZA 8
128 INJECTION SITE SWELLING 8
129 LYMPHADENOPATHY 8
130 NERVOUS SYSTEM DISORDER 8
131 NEUTROPENIA 8
132 PLACENTAL OEDEMA 8
133 POLLAKIURIA 8
134 RASH PRURITIC 8
135 SEPSIS 8
136 SEPTIC SHOCK 8
137 SERUM SICKNESS 8
138 SKIN HAEMORRHAGE 8
139 SWELLING 8
140 TROPONIN INCREASED 8
141 ACUTE KIDNEY INJURY 7
142 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 7
143 ANAPHYLACTIC REACTION 7
144 ASPARTATE AMINOTRANSFERASE INCREASED 7
145 BLOOD CREATININE INCREASED 7
146 BLOOD POTASSIUM DECREASED 7
147 FAECES DISCOLOURED 7
148 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7
149 HAEMATURIA 7
150 HAEMOLYTIC ANAEMIA 7
151 HAEMORRHOIDS 7
152 HYPOAESTHESIA 7
153 HYPOTENSION 7
154 IMMUNE THROMBOCYTOPENIA 7
155 INJECTION SITE DISCOLOURATION 7
156 INJECTION SITE REACTION 7
157 MEAN CELL VOLUME ABNORMAL 7
158 MENSTRUATION IRREGULAR 7
159 MIGRAINE 7
160 MOUTH HAEMORRHAGE 7
161 PERICARDIAL EFFUSION 7
162 PRODUCT USE ISSUE 7
163 SKIN DISCOLOURATION 7
164 URINARY TRACT INFECTION 7
165 ABDOMINAL PAIN UPPER 6
166 CHROMATURIA 6
167 CONFUSIONAL STATE 6
168 DEHYDRATION 6
169 DEPRESSION 6
170 GENERAL PHYSICAL HEALTH DETERIORATION 6
171 HAEMORRHAGE INTRACRANIAL 6
172 INJECTION SITE IRRITATION 6
173 INJECTION SITE URTICARIA 6
174 LIVER FUNCTION TEST ABNORMAL 6
175 MELAENA 6
176 MENORRHAGIA 6
177 MOBILITY DECREASED 6
178 OROPHARYNGEAL PAIN 6
179 PLACENTAL INSUFFICIENCY 6
180 PRE-ECLAMPSIA 6
181 PRODUCT DOSE OMISSION 6
182 RASH ERYTHEMATOUS 6
183 STEROID DIABETES 6
184 SUBDURAL HAEMATOMA 6
185 THERAPEUTIC RESPONSE DECREASED 6
186 THROMBOTIC MICROANGIOPATHY 6
187 VISUAL IMPAIRMENT 6
188 ABDOMINAL DISCOMFORT 5
189 ADVERSE DRUG REACTION 5
190 AGITATION 5
191 BLOOD GLUCOSE ABNORMAL 5
192 BLOOD PRESSURE DECREASED 5
193 DIALYSIS 5
194 DRUG HYPERSENSITIVITY 5
195 FEELING HOT 5
196 FOETAL DEATH 5
197 FOETAL DISTRESS SYNDROME 5
198 FOOD POISONING 5
199 GINGIVAL PAIN 5
200 HEPARIN-INDUCED THROMBOCYTOPENIA 5
201 INTERMENSTRUAL BLEEDING 5
202 IRRITABILITY 5
203 LYMPHOCYTE COUNT DECREASED 5
204 MEMORY IMPAIRMENT 5
205 MOOD SWINGS 5
206 MUCOSAL HAEMORRHAGE 5
207 MUSCULAR WEAKNESS 5
208 NASAL CONGESTION 5
209 PALLOR 5
210 PRODUCT QUALITY ISSUE 5
211 PULMONARY ALVEOLAR HAEMORRHAGE 5
212 RED CELL DISTRIBUTION WIDTH INCREASED 5
213 SHOCK HAEMORRHAGIC 5
214 SOMNOLENCE 5
215 SPEECH DISORDER 5
216 SYSTEMIC LUPUS ERYTHEMATOSUS 5
217 TACHYCARDIA 5
218 THERAPY NON-RESPONDER 5
219 THROAT TIGHTNESS 5
220 THROMBOCYTOSIS 5
221 TRAUMATIC HAEMORRHAGE 5
222 UPPER GASTROINTESTINAL HAEMORRHAGE 5
223 WEIGHT DECREASED 5
224 ABDOMINAL TENDERNESS 4
225 ADAMTS13 ACTIVITY INCREASED 4
226 AGEUSIA 4
227 BACTERAEMIA 4
228 BLOOD PRESSURE ABNORMAL 4
229 BLOOD URINE PRESENT 4
230 BONE PAIN 4
231 BRADYPHRENIA 4
232 BRAIN FOG 4
233 BRAIN OEDEMA 4
234 BRONCHOPULMONARY ASPERGILLOSIS 4
235 CHEST DISCOMFORT 4
236 COMA 4
237 DEPRESSED MOOD 4
238 DEVICE RELATED INFECTION 4
239 DYSPEPSIA 4
240 DYSSTASIA 4
241 EMOTIONAL DISORDER 4
242 FIBRIN D DIMER INCREASED 4
243 FLATULENCE 4
244 GASTROOESOPHAGEAL REFLUX DISEASE 4
245 HAEMOLYSIS 4
246 HEART RATE INCREASED 4
247 HEMIPARESIS 4
248 HUMORAL IMMUNE DEFECT 4
249 INCOHERENT 4
250 INFUSION RELATED REACTION 4
251 INTERNAL HAEMORRHAGE 4
252 INTESTINAL HAEMORRHAGE 4
253 LIMB INJURY 4
254 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4
255 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 4
256 MEAN CELL VOLUME INCREASED 4
257 MENSTRUAL DISORDER 4
258 MYOCARDIAL INFARCTION 4
259 NEUROTOXICITY 4
260 NEUTROPHIL COUNT ABNORMAL 4
261 NEUTROPHIL COUNT INCREASED 4
262 OBESITY 4
263 PNEUMOCYSTIS JIROVECII PNEUMONIA 4
264 POOR QUALITY PRODUCT ADMINISTERED 4
265 POST PROCEDURAL HAEMORRHAGE 4
266 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4
267 PRODUCT PREPARATION ISSUE 4
268 PURPURA 4
269 REBOUND EFFECT 4
270 RED CELL DISTRIBUTION WIDTH ABNORMAL 4
271 RESPIRATORY FAILURE 4
272 RHINORRHOEA 4
273 SKIN REACTION 4
274 SLEEP DISORDER 4
275 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4
276 STRESS 4
277 SUBARACHNOID HAEMORRHAGE 4
278 SURGERY 4
279 TASTE DISORDER 4
280 TOXICITY TO VARIOUS AGENTS 4
281 TRANSFUSION 4
282 VISION BLURRED 4
283 WHITE BLOOD CELL COUNT DECREASED 4
284 ACUTE RESPIRATORY DISTRESS SYNDROME 3
285 ADAMTS13 INHIBITOR SCREEN ASSAY 3
286 ASTHMA 3
287 BACTERIAL INFECTION 3
288 BALANCE DISORDER 3
289 BLEEDING TIME PROLONGED 3
290 BLOOD IRON DECREASED 3
291 BLOOD LACTATE DEHYDROGENASE DECREASED 3
292 BLOOD UREA INCREASED 3
293 BRADYCARDIA 3
294 CARDIAC DISORDER 3
295 CARDIAC FAILURE 3
296 CONJUNCTIVAL HAEMORRHAGE 3
297 DECREASED ACTIVITY 3
298 DECREASED APPETITE 3
299 DEPRESSED LEVEL OF CONSCIOUSNESS 3
300 DISCOMFORT 3
301 DISORIENTATION 3
302 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
303 DYSARTHRIA 3
304 DYSPHONIA 3
305 EMBOLISM VENOUS 3
306 FEELING COLD 3
307 FEELING JITTERY 3
308 FLUID RETENTION 3
309 FLUSHING 3
310 GLOMERULAR FILTRATION RATE DECREASED 3
311 GRANULOCYTES ABNORMAL 3
312 HAEMOGLOBINAEMIA 3
313 HAPTOGLOBIN DECREASED 3
314 HEMIPLEGIA 3
315 HEPATIC ENZYME INCREASED 3
316 HEPATOTOXICITY 3
317 HERPES ZOSTER 3
318 HUNGER 3
319 INCREASED APPETITE 3
320 INFUSION SITE BRUISING 3
321 INFUSION SITE HAEMORRHAGE 3
322 INJECTION SITE EXTRAVASATION 3
323 INJECTION SITE SCAB 3
324 INTENTIONAL DOSE OMISSION 3
325 INTENTIONAL PRODUCT MISUSE 3
326 LIMB DISCOMFORT 3
327 LIP HAEMORRHAGE 3
328 LOSS OF CONSCIOUSNESS 3
329 LUNG DISORDER 3
330 LYMPHOCYTE PERCENTAGE ABNORMAL 3
331 MEAN CELL HAEMOGLOBIN INCREASED 3
332 MEAN PLATELET VOLUME DECREASED 3
333 MENTAL STATUS CHANGES 3
334 METRORRHAGIA 3
335 MOVEMENT DISORDER 3
336 NASAL DRYNESS 3
337 NEUROPATHY PERIPHERAL 3
338 NIGHT SWEATS 3
339 OCULAR HYPERAEMIA 3
340 OEDEMA PERIPHERAL 3
341 OPHTHALMIC HERPES SIMPLEX 3
342 ORAL CANDIDIASIS 3
343 ORAL HERPES 3
344 ORAL PAIN 3
345 ORGAN FAILURE 3
346 OXYGEN SATURATION DECREASED 3
347 PANCREATITIS 3
348 PHARYNGEAL SWELLING 3
349 PHOTOPHOBIA 3
350 POOR QUALITY SLEEP 3
351 POSTOPERATIVE WOUND INFECTION 3
352 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3
353 PRODUCT ADMINISTRATION ERROR 3
354 PRODUCT PRESCRIBING ISSUE 3
355 PRODUCT RECONSTITUTION QUALITY ISSUE 3
356 PULMONARY HAEMORRHAGE 3
357 PULMONARY OEDEMA 3
358 RASH PAPULAR 3
359 RED BLOOD CELL SCHISTOCYTES PRESENT 3
360 RENAL DISORDER 3
361 RETICULOCYTE COUNT INCREASED 3
362 SENSORY DISTURBANCE 3
363 SERRATIA INFECTION 3
364 SKIN ABRASION 3
365 SMALL INTESTINAL HAEMORRHAGE 3
366 SPINAL FRACTURE 3
367 THIRST 3
368 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 3
369 VON WILLEBRAND^S FACTOR ACTIVITY DECREASED 3
370 VON WILLEBRAND^S FACTOR ANTIGEN INCREASED 3
371 ABDOMINAL WALL HAEMATOMA 2
372 ABORTION SPONTANEOUS 2
373 ACUTE MYOCARDIAL INFARCTION 2
374 AGRANULOCYTOSIS 2
375 ALOPECIA 2
376 ALTERED STATE OF CONSCIOUSNESS 2
377 AMNESIA 2
378 ANAL HAEMORRHAGE 2
379 ANTIBODY TEST ABNORMAL 2
380 ANTIBODY TEST POSITIVE 2
381 APHASIA 2
382 ARRHYTHMIA 2
383 ASPARTATE AMINOTRANSFERASE ABNORMAL 2
384 ATRIAL FIBRILLATION 2
385 BLINDNESS 2
386 BLISTER 2
387 BLOOD ALBUMIN DECREASED 2
388 BLOOD CHLORIDE ABNORMAL 2
389 BLOOD CHOLESTEROL INCREASED 2
390 BLOOD CREATININE ABNORMAL 2
391 BLOOD DISORDER 2
392 BLOOD IRON ABNORMAL 2
393 BLOOD POTASSIUM INCREASED 2
394 BLOOD TEST ABNORMAL 2
395 BLOOD UREA ABNORMAL 2
396 BRAIN HERNIATION 2
397 BURNING SENSATION 2
398 C-REACTIVE PROTEIN INCREASED 2
399 CANDIDA INFECTION 2
400 CARBON DIOXIDE ABNORMAL 2
401 CELLULITIS 2
402 CENTRAL VENOUS CATHETER REMOVAL 2
403 CHAPPED LIPS 2
404 CHOLECYSTITIS 2
405 CHOLELITHIASIS 2
406 CHOLESTASIS 2
407 CIRCULATORY COLLAPSE 2
408 CRYING 2
409 CUSHINGOID 2
410 CYSTITIS 2
411 CYTOMEGALOVIRUS INFECTION 2
412 DEAFNESS 2
413 DELIRIUM 2
414 DIABETES MELLITUS 2
415 DRUG SPECIFIC ANTIBODY PRESENT 2
416 DRY SKIN 2
417 DYSPHAGIA 2
418 DYSPNOEA EXERTIONAL 2
419 ECCHYMOSIS 2
420 EXPOSURE DURING PREGNANCY 2
421 FINE MOTOR SKILL DYSFUNCTION 2
422 FULL BLOOD COUNT DECREASED 2
423 FUNGAL INFECTION 2
424 FURUNCLE 2
425 GAIT INABILITY 2
426 GASTRIC HAEMORRHAGE 2
427 GASTRIC ULCER 2
428 GASTROENTERITIS SALMONELLA 2
429 HAEMODIALYSIS 2
430 HAEMORRHAGIC DIATHESIS 2
431 HAEMORRHAGIC STROKE 2
432 HAPTOGLOBIN ABNORMAL 2
433 HEAD INJURY 2
434 HEART RATE ABNORMAL 2
435 HEPATOCELLULAR INJURY 2
436 HYDROPS FOETALIS 2
437 HYPERMETROPIA 2
438 HYPERPHAGIA 2
439 HYPOAESTHESIA ORAL 2
440 HYPOKALAEMIA 2
441 INHIBITING ANTIBODIES 2
442 INJECTION SITE EROSION 2
443 INJECTION SITE HAEMATOMA 2
444 INJECTION SITE HYPERSENSITIVITY 2
445 INJECTION SITE INFLAMMATION 2
446 INJECTION SITE PLAQUE 2
447 INJURY 2
448 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2
449 INTERCEPTED PRODUCT STORAGE ERROR 2
450 LACUNAR INFARCTION 2
451 LOCALISED INFECTION 2
452 LOWER GASTROINTESTINAL HAEMORRHAGE 2
453 LUNG CONSOLIDATION 2
454 LYMPHOCYTE PERCENTAGE DECREASED 2
455 LYMPHOCYTOSIS 2
456 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2
457 MEAN CELL HAEMOGLOBIN DECREASED 2
458 MITRAL VALVE INCOMPETENCE 2
459 MONOCYTE COUNT INCREASED 2
460 MOTOR DYSFUNCTION 2
461 MOUTH ULCERATION 2
462 MULTIMORBIDITY 2
463 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2
464 MUSCLE ATROPHY 2
465 MUSCLE TONE DISORDER 2
466 MYOCLONUS 2
467 NASAL DISCOMFORT 2
468 NASOPHARYNGITIS 2
469 NEOPLASM MALIGNANT 2
470 NEPHROLITHIASIS 2
471 NERVOUSNESS 2
472 NEUROLOGIC NEGLECT SYNDROME 2
473 NEUTROPHIL PERCENTAGE INCREASED 2
474 ORAL BLOOD BLISTER 2
475 OSTEOMYELITIS 2
476 PANCYTOPENIA 2
477 PARAESTHESIA ORAL 2
478 PERFORMANCE STATUS DECREASED 2
479 PERIPHERAL ARTERY THROMBOSIS 2
480 PIGMENTATION DISORDER 2
481 PLEURAL EFFUSION 2
482 POST PROCEDURAL HAEMATOMA 2
483 POST TRANSFUSION PURPURA 2
484 PREGNANCY 2
485 PREMATURE BABY 2
486 PRODUCT PREPARATION ERROR 2
487 PRODUCT USED FOR UNKNOWN INDICATION 2
488 RED BLOOD CELL COUNT INCREASED 2
489 RETICULOCYTE COUNT ABNORMAL 2
490 RETICULOCYTE PERCENTAGE INCREASED 2
491 SCAB 2
492 SCRATCH 2
493 SHOULDER FRACTURE 2
494 SINUS DISORDER 2
495 SINUSITIS 2
496 SKIN IRRITATION 2
497 SKIN LESION 2
498 SKIN SWELLING 2
499 SKIN ULCER 2
500 SPLENECTOMY 2
501 STAPHYLOCOCCAL BACTERAEMIA 2
502 STAPHYLOCOCCAL INFECTION 2
503 SUBCUTANEOUS HAEMATOMA 2
504 SUBDURAL HAEMORRHAGE 2
505 SUPRAVENTRICULAR TACHYCARDIA 2
506 SUSPECTED COVID-19 2
507 TERMINAL INSOMNIA 2
508 THROMBOCYTOPENIC PURPURA 2
509 THYROID DISORDER 2
510 TRANCE 2
511 TRANSAMINASES INCREASED 2
512 TREATMENT NONCOMPLIANCE 2
513 UPPER RESPIRATORY TRACT INFECTION 2
514 URINE ODOUR ABNORMAL 2
515 VITAMIN D DECREASED 2
516 WOUND SECRETION 2
517 ABDOMINAL INJURY 1
518 ABDOMINAL RIGIDITY 1
519 ABNORMAL DREAMS 1
520 ABNORMAL MENSTRUAL CLOTS 1
521 ABSCESS ORAL 1
522 ACCIDENTAL EXPOSURE TO PRODUCT 1
523 ACINETOBACTER TEST POSITIVE 1
524 ACQUIRED VON WILLEBRAND^S DISEASE 1
525 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1
526 ACUTE CORONARY SYNDROME 1
527 ACUTE RESPIRATORY FAILURE 1
528 ADAMTS13 ACTIVITY ASSAY 1
529 ADMINISTRATION SITE PAIN 1
530 ADVERSE EVENT 1
531 ADVERSE REACTION 1
532 AEROMONAS INFECTION 1
533 AFFECT LABILITY 1
534 AIR EMBOLISM 1
535 ALANINE AMINOTRANSFERASE ABNORMAL 1
536 ALBUMIN GLOBULIN RATIO INCREASED 1
537 ALVEOLITIS 1
538 ANAL FISSURE 1
539 ANAPHYLACTIC SHOCK 1
540 ANGER 1
541 ANGIOPATHY 1
542 ANOSMIA 1
543 ANTINUCLEAR ANTIBODY POSITIVE 1
544 ANXIETY DISORDER 1
545 AORTIC ANEURYSM 1
546 AORTIC THROMBOSIS 1
547 APPLICATION SITE BRUISE 1
548 ARTERIAL HAEMORRHAGE 1
549 ARTHROPOD STING 1
550 ASPHYXIA 1
551 ASPIRATION 1
552 ASPIRATION PLEURAL CAVITY 1
553 ASTHENOPIA 1
554 ATONIC SEIZURES 1
555 ATRIAL THROMBOSIS 1
556 BACK DISORDER 1
557 BACTERIAL DISEASE CARRIER 1
558 BEDRIDDEN 1
559 BENIGN RENAL NEOPLASM 1
560 BICYTOPENIA 1
561 BILE DUCT STONE 1
562 BLEEDING TIME ABNORMAL 1
563 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1
564 BLOOD ALBUMIN ABNORMAL 1
565 BLOOD ALBUMIN INCREASED 1
566 BLOOD ALKALINE PHOSPHATASE DECREASED 1
567 BLOOD ALKALINE PHOSPHATASE INCREASED 1
568 BLOOD BLISTER 1
569 BLOOD CALCIUM DECREASED 1
570 BLOOD CHLORIDE DECREASED 1
571 BLOOD CHLORIDE INCREASED 1
572 BLOOD COUNT ABNORMAL 1
573 BLOOD CREATININE DECREASED 1
574 BLOOD FIBRINOGEN INCREASED 1
575 BLOOD GLUCAGON DECREASED 1
576 BLOOD GLUCOSE DECREASED 1
577 BLOOD GLUCOSE FLUCTUATION 1
578 BLOOD PHOSPHORUS DECREASED 1
579 BLOOD POTASSIUM ABNORMAL 1
580 BLOOD PRESSURE FLUCTUATION 1
581 BLOOD PRESSURE SYSTOLIC INCREASED 1
582 BLOOD SODIUM DECREASED 1
583 BLOOD URINE 1
584 BRADYKINESIA 1
585 BRAIN HYPOXIA 1
586 BRONCHIAL HAEMORRHAGE 1
587 BRONCHITIS 1
588 BRONCHOALVEOLAR LAVAGE 1
589 CANDIDA SEPSIS 1
590 CARDIAC ANEURYSM 1
591 CARDIAC OPERATION 1
592 CARDIAC PERFUSION DEFECT 1
593 CARDIAC TAMPONADE 1
594 CARDIO-RESPIRATORY ARREST 1
595 CARDIOGENIC SHOCK 1
596 CARDIOPULMONARY FAILURE 1
597 CARDIOSPASM 1
598 CARPAL TUNNEL DECOMPRESSION 1
599 CASTLEMAN^S DISEASE 1
600 CATARACT 1
601 CATHETER REMOVAL 1
602 CATHETER SITE BRUISE 1
603 CATHETER SITE HAEMATOMA 1
604 CATHETER SITE PAIN 1
605 CATHETER SITE SWELLING 1
606 CATHETER SITE THROMBOSIS 1
607 CENTRAL VENOUS CATHETERISATION 1
608 CEREBELLAR INFARCTION 1
609 CEREBRAL ARTERY OCCLUSION 1
610 CEREBRAL DISORDER 1
611 CEREBRAL ISCHAEMIA 1
612 CEREBRAL MASS EFFECT 1
613 CEREBRAL MICROHAEMORRHAGE 1
614 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1
615 CHOLECYSTITIS ACUTE 1
616 CHRONIC DISEASE 1
617 CHRONIC KIDNEY DISEASE 1
618 CHRONIC LYMPHOCYTIC LEUKAEMIA 1
619 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
620 CLOSTRIDIUM DIFFICILE COLITIS 1
621 CLOSTRIDIUM DIFFICILE INFECTION 1
622 COITAL BLEEDING 1
623 COLD SWEAT 1
624 COMPLEMENT FACTOR DECREASED 1
625 COMPRESSION GARMENT APPLICATION 1
626 COMPUTERISED TOMOGRAM ABNORMAL 1
627 CONJUNCTIVITIS 1
628 CORNEAL ABRASION 1
629 CORONARY ARTERY BYPASS 1
630 CORONARY ARTERY DISEASE 1
631 CORONARY ARTERY OCCLUSION 1
632 CORONAVIRUS TEST POSITIVE 1
633 COVID-19 PNEUMONIA 1
634 CRANIOTOMY 1
635 CRITICAL ILLNESS 1
636 CULTURE URINE POSITIVE 1
637 CYSTITIS HAEMORRHAGIC 1
638 CYTOMEGALOVIRUS INFECTION REACTIVATION 1
639 DERMAL CYST 1
640 DERMATITIS ACNEIFORM 1
641 DERMATITIS ALLERGIC 1
642 DEVICE ISSUE 1
643 DIABETES MELLITUS INADEQUATE CONTROL 1
644 DIABETIC KETOACIDOSIS 1
645 DIARRHOEA HAEMORRHAGIC 1
646 DISABILITY 1
647 DISCHARGE 1
648 DISCOLOURED VOMIT 1
649 DISCOURAGEMENT 1
650 DISEASE COMPLICATION 1
651 DISTURBANCE IN ATTENTION 1
652 DROOLING 1
653 DRUG DELIVERY SYSTEM ISSUE 1
654 DRUG INTOLERANCE 1
655 DRY MOUTH 1
656 DUODENITIS 1
657 DYSGEUSIA 1
658 DYSMENORRHOEA 1
659 DYSURIA 1
660 EAR DISORDER 1
661 EAR HAEMORRHAGE 1
662 EAR INFECTION 1
663 EAR PAIN 1
664 EATING DISORDER 1
665 ECZEMA 1
666 ELECTROCARDIOGRAM CHANGE 1
667 EMBOLIC CEREBELLAR INFARCTION 1
668 EMBOLIC STROKE 1
669 EMBOLISM 1
670 EMOTIONAL DISTRESS 1
671 ENCEPHALOMALACIA 1
672 ENCEPHALOPATHY 1
673 ENTEROBACTER TEST POSITIVE 1
674 EOSINOPHIL COUNT DECREASED 1
675 EOSINOPHIL PERCENTAGE DECREASED 1
676 EPILEPSY 1
677 EPSTEIN-BARR VIRAEMIA 1
678 EPSTEIN-BARR VIRUS INFECTION 1
679 EXPOSURE VIA SKIN CONTACT 1
680 EYE DISORDER 1
681 EYE HAEMORRHAGE 1
682 EYE INFLAMMATION 1
683 EYE PAIN 1
684 EYELID HAEMATOMA 1
685 FACIAL PAIN 1
686 FACTOR VIII ACTIVITY INCREASED 1
687 FAT TISSUE INCREASED 1
688 FEAR OF INJECTION 1
689 FEBRILE NEUTROPENIA 1
690 FLUID OVERLOAD 1
691 FOETAL HEART RATE ABNORMAL 1
692 FORMICATION 1
693 FREQUENT BOWEL MOVEMENTS 1
694 FRONTOTEMPORAL DEMENTIA 1
695 FRUSTRATION TOLERANCE DECREASED 1
696 FULL BLOOD COUNT ABNORMAL 1
697 FULL BLOOD COUNT INCREASED 1
698 GASTRIC PH DECREASED 1
699 GASTRITIS 1
700 GASTROENTERITIS VIRAL 1
701 GASTROINTESTINAL DISORDER 1
702 GASTROINTESTINAL INJURY 1
703 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1
704 GENERALISED OEDEMA 1
705 GENITAL HAEMORRHAGE 1
706 GENITAL INJURY 1
707 GINGIVAL DISCOMFORT 1
708 GINGIVAL DISORDER 1
709 GINGIVAL ULCERATION 1
710 GLOBULINS DECREASED 1
711 GLOMERULAR FILTRATION RATE ABNORMAL 1
712 GLOMERULONEPHRITIS 1
713 GOITRE 1
714 GRIP STRENGTH DECREASED 1
715 GROWTH RETARDATION 1
716 HAEMARTHROSIS 1
717 HAEMATOCRIT INCREASED 1
718 HAEMODYNAMIC INSTABILITY 1
719 HAEMOFILTRATION 1
720 HAEMOGLOBIN INCREASED 1
721 HAEMOPERITONEUM 1
722 HAEMORRHAGIC INFARCTION 1
723 HAEMORRHAGIC PANCREATIC CYST 1
724 HAIR GROWTH RATE ABNORMAL 1
725 HAIR TEXTURE ABNORMAL 1
726 HALLUCINATION 1
727 HEAD DISCOMFORT 1
728 HEART RATE DECREASED 1
729 HELICOBACTER INFECTION 1
730 HEMIANOPIA HOMONYMOUS 1
731 HEPATIC CYTOLYSIS 1
732 HEPATIC FAILURE 1
733 HEPATIC FUNCTION ABNORMAL 1
734 HEPATIC PAIN 1
735 HEPATITIS 1
736 HEPATITIS B 1
737 HEPATITIS E VIRUS TEST POSITIVE 1
738 HERPES SIMPLEX 1
739 HIGH DENSITY LIPOPROTEIN INCREASED 1
740 HIP ARTHROPLASTY 1
741 HIV INFECTION 1
742 HOSPICE CARE 1
743 HYPERBILIRUBINAEMIA 1
744 HYPERCAPNIA 1
745 HYPERCHLORHYDRIA 1
746 HYPERCREATININAEMIA 1
747 HYPERGLYCAEMIA 1
748 HYPERKALAEMIA 1
749 HYPERSOMNIA 1
750 HYPOKINESIA 1
751 HYPOPHOSPHATAEMIA 1
752 HYPOVOLAEMIA 1
753 HYPOVOLAEMIC SHOCK 1
754 HYPOXIA 1
755 ILL-DEFINED DISORDER 1
756 IMMATURE GRANULOCYTE COUNT INCREASED 1
757 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1
758 IMMUNE SYSTEM DISORDER 1
759 IMMUNOGLOBULINS ABNORMAL 1
760 IMPAIRED HEALING 1
761 IMPAIRED QUALITY OF LIFE 1
762 IMPAIRED WORK ABILITY 1
763 INCREASED TENDENCY TO BRUISE 1
764 INFECTION PARASITIC 1
765 INFLAMMATION 1
766 INJECTION SITE COLDNESS 1
767 INJECTION SITE DERMATITIS 1
768 INJECTION SITE DISCOMFORT 1
769 INJECTION SITE DRYNESS 1
770 INJECTION SITE INDURATION 1
771 INJECTION SITE MASS 1
772 INJECTION SITE OEDEMA 1
773 INJECTION SITE PARAESTHESIA 1
774 INJECTION SITE VESICLES 1
775 INJURY ASSOCIATED WITH DEVICE 1
776 INTENTIONAL SELF-INJURY 1
777 INTERCEPTED PRODUCT DISPENSING ERROR 1
778 INTERCEPTED PRODUCT PREPARATION ERROR 1
779 INTERMITTENT CLAUDICATION 1
780 INTERNATIONAL NORMALISED RATIO INCREASED 1
781 INTESTINAL GANGRENE 1
782 INTESTINAL INFARCTION 1
783 INTESTINAL ISCHAEMIA 1
784 INTRACARDIAC THROMBUS 1
785 INTRAVENTRICULAR HAEMORRHAGE 1
786 IRON DEFICIENCY 1
787 IRON DEFICIENCY ANAEMIA 1
788 ISCHAEMIA 1
789 JAUNDICE 1
790 JOINT DISLOCATION 1
791 JOINT STIFFNESS 1
792 JUGULAR VEIN THROMBOSIS 1
793 KLEBSIELLA INFECTION 1
794 KNEE ARTHROPLASTY 1
795 LACK OF INJECTION SITE ROTATION 1
796 LACK OF SATIETY 1
797 LACRIMATION INCREASED 1
798 LACTIC ACIDOSIS 1
799 LARYNGEAL OEDEMA 1
800 LARYNGITIS 1
801 LARYNGOSPASM 1
802 LETHARGY 1
803 LIP SCAB 1
804 LIP SWELLING 1
805 LIQUID PRODUCT PHYSICAL ISSUE 1
806 LIVER FUNCTION TEST INCREASED 1
807 LUNG OPACITY 1
808 LYMPHOCYTE COUNT ABNORMAL 1
809 MEAN PLATELET VOLUME ABNORMAL 1
810 MEDICAL DEVICE SITE HAEMORRHAGE 1
811 MEDICAL DEVICE SITE PRURITUS 1
812 MEDICATION ERROR 1
813 MENSTRUATION DELAYED 1
814 MENTAL DISORDER 1
815 MILIARIA 1
816 MITRAL VALVE PROLAPSE 1
817 MONOCYTE COUNT ABNORMAL 1
818 MONOCYTE PERCENTAGE ABNORMAL 1
819 MONOCYTE PERCENTAGE INCREASED 1
820 MOUTH INJURY 1
821 MUCOSAL PAIN 1
822 MULTI-ORGAN DISORDER 1
823 MULTIPLE SCLEROSIS RELAPSE 1
824 MULTISYSTEM INFLAMMATORY SYNDROME 1
825 MUSCLE FATIGUE 1
826 MUSCULOSKELETAL CHEST PAIN 1
827 MUSCULOSKELETAL STIFFNESS 1
828 MYDRIASIS 1
829 MYOCLONIC EPILEPSY 1
830 MYOPATHY 1
831 NAIL BED BLEEDING 1
832 NASAL DISCHARGE DISCOLOURATION 1
833 NECROSIS 1
834 NEOPLASM 1
835 NEPHROPATHY 1
836 NEPHROPATHY TOXIC 1
837 NEPHROTIC SYNDROME 1
838 NEUROLOGICAL DECOMPENSATION 1
839 NONINFECTIVE GINGIVITIS 1
840 NORMOCHROMIC NORMOCYTIC ANAEMIA 1
841 NUCLEATED RED CELLS 1
842 OEDEMA 1
843 OESOPHAGEAL CANDIDIASIS 1
844 ORAL DISORDER 1
845 ORAL MUCOSAL BLISTERING 1
846 ORTHOSTATIC HYPOTENSION 1
847 OSTEOGENESIS IMPERFECTA 1
848 OSTEONECROSIS 1
849 OSTEOPOROSIS 1
850 OTORRHOEA 1
851 OVARIAN CANCER 1
852 OVARIAN CYST 1
853 PAIN IN JAW 1
854 PANCREATIC CARCINOMA 1
855 PANCREATIC DISORDER 1
856 PANCREATIC PSEUDOCYST 1
857 PANCREATITIS NECROTISING 1
858 PANIC REACTION 1
859 PARALYSIS 1
860 PARANASAL SINUS HAEMORRHAGE 1
861 PARANEOPLASTIC SYNDROME 1
862 PARVOVIRUS B19 TEST POSITIVE 1
863 PELVIC VENOUS THROMBOSIS 1
864 PERIPHERAL VEIN THROMBUS EXTENSION 1
865 PERSONALITY CHANGE 1
866 PETIT MAL EPILEPSY 1
867 PHARYNGEAL OEDEMA 1
868 PHOTOSENSITIVITY REACTION 1
869 PLASMA CELL MYELOMA 1
870 PLASMABLASTIC LYMPHOMA 1
871 PLASMAPHERESIS 1
872 PLATELET AGGREGATION 1
873 PLATELET DISORDER 1
874 PLATELET DYSFUNCTION 1
875 PNEUMOCOCCAL SEPSIS 1
876 PNEUMOCYSTIS JIROVECII INFECTION 1
877 PNEUMONIA ASPIRATION 1
878 PNEUMONIA BACTERIAL 1
879 PNEUMONIA CYTOMEGALOVIRAL 1
880 PNEUMONIA FUNGAL 1
881 PNEUMONIA NECROTISING 1
882 PNEUMONIA VIRAL 1
883 PNEUMOTHORAX 1
884 POLYCHROMASIA 1
885 POSTERIOR TIBIAL TENDON DYSFUNCTION 1
886 PREGNANCY TEST POSITIVE 1
887 PREMATURE DELIVERY 1
888 PREMENSTRUAL PAIN 1
889 PRESYNCOPE 1
890 PROCEDURAL PAIN 1
891 PRODUCT ADMINISTRATION INTERRUPTED 1
892 PRODUCT CONTAINER ISSUE 1
893 PRODUCT CONTAMINATION 1
894 PRODUCT DISPENSING ISSUE 1
895 PRODUCT DOSE OMISSION IN ERROR 1
896 PRODUCT LEAKAGE 1
897 PRODUCT PACKAGING DIFFICULT TO OPEN 1
898 PRODUCT PACKAGING ISSUE 1
899 PRODUCT PHYSICAL ISSUE 1
900 PRODUCT STORAGE ISSUE 1
901 PRODUCTIVE COUGH 1
902 PROSTATIC DYSPLASIA 1
903 PROTEIN TOTAL DECREASED 1
904 PROTEINURIA 1
905 PSYCHIATRIC DECOMPENSATION 1
906 PULMONARY HYPERTENSION 1
907 PULMONARY THROMBOSIS 1
908 PUPILS UNEQUAL 1
909 PUSTULE 1
910 PYELONEPHRITIS 1
911 QUADRIPLEGIA 1
912 RECTAL DISCHARGE 1
913 RECTAL ULCER 1
914 RED BLOOD CELL ABNORMALITY 1
915 RED BLOOD CELL ANISOCYTES PRESENT 1
916 RED BLOOD CELL MICROCYTES PRESENT 1
917 RED BLOOD CELL POIKILOCYTES PRESENT 1
918 RED BLOOD CELLS URINE 1
919 RED CELL DISTRIBUTION WIDTH DECREASED 1
920 RENAL FAILURE 1
921 RENAL INFARCT 1
922 RENAL PAIN 1
923 RENAL TUBULAR NECROSIS 1
924 RESPIRATION ABNORMAL 1
925 RESPIRATORY DISORDER 1
926 RESPIRATORY TRACT CONGESTION 1
927 RESPIRATORY TRACT INFECTION 1
928 RETCHING 1
929 RETICULOCYTE PERCENTAGE ABNORMAL 1
930 RETINAL HAEMORRHAGE 1
931 RHEUMATOID ARTHRITIS 1
932 RHINOVIRUS INFECTION 1
933 ROCKY MOUNTAIN SPOTTED FEVER 1
934 SARS-COV-2 TEST POSITIVE 1
935 SCHISTOCYTOSIS 1
936 SCIATICA 1
937 SCREAMING 1
938 SEASONAL ALLERGY 1
939 SECRETION DISCHARGE 1
940 SENSITIVE SKIN 1
941 SENSORY LOSS 1
942 SEPTIC PHLEBITIS 1
943 SIGNET-RING CELL CARCINOMA 1
944 SINUS CONGESTION 1
945 SKIN MASS 1
946 SKIN WARM 1
947 SKIN WEEPING 1
948 SNORING 1
949 SOMATIC SYMPTOM DISORDER 1
950 SPLEEN DISORDER 1
951 SPLENIC ARTERY EMBOLISATION 1
952 SPLENIC INFARCTION 1
953 SPLENIC VEIN THROMBOSIS 1
954 SPLENOMEGALY 1
955 SPONTANEOUS HAEMATOMA 1
956 SPUTUM DISCOLOURED 1
957 STEATORRHOEA 1
958 STENOSIS 1
959 STENT REMOVAL 1
960 STILLBIRTH 1
961 STOMATOCYTES PRESENT 1
962 STRESS ULCER HAEMORRHAGE 1
963 SUBCAPSULAR RENAL HAEMATOMA 1
964 SUBCHORIONIC HAEMATOMA 1
965 SUPERFICIAL VEIN THROMBOSIS 1
966 SUTURE RELATED COMPLICATION 1
967 SYNCOPE 1
968 SYRINGE ISSUE 1
969 SYSTEMIC CANDIDA 1
970 SYSTOLIC HYPERTENSION 1
971 TEMPERATURE INTOLERANCE 1
972 TENDERNESS 1
973 THALAMIC INFARCTION 1
974 THERAPY INTERRUPTED 1
975 THERAPY PARTIAL RESPONDER 1
976 THROMBOLYSIS 1
977 THROMBOPHLEBITIS SUPERFICIAL 1
978 TRACHEITIS 1
979 TRACHEOSTOMY 1
980 TRANSAMINASES ABNORMAL 1
981 TRANSFERRIN SATURATION ABNORMAL 1
982 TRANSFUSION REACTION 1
983 TRANSFUSION-RELATED ACUTE LUNG INJURY 1
984 TRANSIENT ISCHAEMIC ATTACK 1
985 TREATMENT FAILURE 1
986 ULCER 1
987 URINARY INCONTINENCE 1
988 URINARY TRACT DISORDER 1
989 URINE OUTPUT INCREASED 1
990 VAGINAL DISORDER 1
991 VASOCONSTRICTION 1
992 VASOPLEGIA SYNDROME 1
993 VEIN DISORDER 1
994 VENOUS THROMBOSIS LIMB 1
995 VERTIGO 1
996 VIRAL INFECTION 1
997 VIRAL UPPER RESPIRATORY TRACT INFECTION 1
998 VITAL FUNCTIONS ABNORMAL 1
999 VITAMIN B12 DEFICIENCY 1